Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Masimo (MASI)
The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0587 %, meaning that it created $0.0587 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 6.81 B. At this time, the firm appears to be fairly valued. Masimo secures a last-minute Real Value of $130.58 per share. The latest price of the firm is $124.62. Our model forecasts the value of Masimo from analyzing the firm fundamentals such as Current Valuation of 7.61 B, return on equity of 0.0587, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
ICU Medical (ICUI)
The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.01. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 95.8 M, while Net Tangible Assets are forecasted to increase to (373.7 M). ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.69 B.
Net Debt
1.52 Billion
As of now, ICU Medical's Net Debt is increasing as compared to previous years.
Select Medical Holdings (SEM)
The company has Return on Asset of 0.048 % which means that on every $100 spent on assets, it made $0.048 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2127 %, implying that it generated $0.2127 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 5th of June 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year. The firm currently falls under 'Mid-Cap' category with a total capitalization of 4.45 B. At this time, the company appears to be undervalued. Select Medical Holdings has a current Real Value of $37.85 per share. The regular price of the company is $34.43. Our model measures the value of Select Medical Holdings from inspecting the company fundamentals such as Shares Outstanding of 130.03 M, operating margin of 0.11 %, and Return On Equity of 0.21 as well as reviewing its technical indicators and probability of bankruptcy.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
Masimo (MASI)
The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0587 %, meaning that it created $0.0587 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 6.81 B. At this time, the firm appears to be fairly valued. Masimo secures a last-minute Real Value of $130.58 per share. The latest price of the firm is $124.62. Our model forecasts the value of Masimo from analyzing the firm fundamentals such as Current Valuation of 7.61 B, return on equity of 0.0587, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
ICU Medical (ICUI)
The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.01. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 95.8 M, while Net Tangible Assets are forecasted to increase to (373.7 M). ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.69 B.
Net Debt
1.52 Billion
As of now, ICU Medical's Net Debt is increasing as compared to previous years.
Select Medical Holdings (SEM)
The company has Return on Asset of 0.048 % which means that on every $100 spent on assets, it made $0.048 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2127 %, implying that it generated $0.2127 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 5th of June 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year. The firm currently falls under 'Mid-Cap' category with a total capitalization of 4.45 B. At this time, the company appears to be undervalued. Select Medical Holdings has a current Real Value of $37.85 per share. The regular price of the company is $34.43. Our model measures the value of Select Medical Holdings from inspecting the company fundamentals such as Shares Outstanding of 130.03 M, operating margin of 0.11 %, and Return On Equity of 0.21 as well as reviewing its technical indicators and probability of bankruptcy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
